Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vicki L Goodman Insider Profile
4 Followers
Vicki L Goodman, EVP, Prod Dev & Med Aff &CMO at Exelixis, holds 73.02K shares in Mural Oncology Plc (Ticker: MURA), holds 307.65K shares in Exelixis (Ticker: EXEL).
Vicki L Goodman has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Vicki L Goodman holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Vicki L Goodman
Vicki L Goodman's Trading History
Exelixis
Apr 05, 2023
EVP, Prod Dev & Med Aff &CMO
Uninformative Buy
―
$6.95M
Mural Oncology Plc
Dec 18, 2023
Chief Medical Officer
Uninformative Buy
―
$250.45K
List of latest transactions for each holding click on a transaction to see Vicki L Goodman's performance on stock
You May Also Like
Vicki L Goodman insider profile FAQ
What is the percentage of profitable transactions made by Vicki L Goodman?
The percentage of profitable transactions made by Vicki L Goodman is ―.
What is the average return per transaction made by Vicki L Goodman?
The average return per transaction made by Vicki L Goodman is ―.
What stocks does Vicki L Goodman hold?
Vicki L Goodman holds: EXEL, MURA stocks.
What was Vicki L Goodman’s latest transaction?
Vicki L Goodman latest transaction was an Uninformative Buy of ―.
What was Vicki L Goodman's most profitable transaction?
Vicki L Goodman’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Vicki L Goodman's role in Exelixis?
Vicki L Goodman's role in Exelixis is EVP, Prod Dev & Med Aff &CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.